Last updated on August 2019

A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus


Brief description of study

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.

Clinical Study Identifier: NCT03736785

Find a site near you

Start Over

Arkansas Clinical Research

Little Rock, AR United States
  Connect »

AMCR Institute INC

Escondido, CA United States
  Connect »

Valley Endocrine, Fresno

Fresno, CA United States
  Connect »

Marin Endocrine Associates

Greenbrae, CA United States
  Connect »

National Research Institute

Huntington Park, CA United States
  Connect »

First Valley Medical Group

Lancaster, CA United States
  Connect »

National Research Institute

Los Angeles, CA United States
  Connect »

Chase Medical Research, LLC

Waterbury, CT United States
  Connect »

ALL Medical Research, LLC

Cooper City, FL United States
  Connect »

Suncoast Clinical Research

New Port Richey, FL United States
  Connect »

Metabolic Research Institute Inc.

West Palm Beach, FL United States
  Connect »

East West Medical Institute

Honolulu, HI United States
  Connect »

Elite Clinical Trials LLLP

Blackfoot, ID United States
  Connect »

Iderc, P.L.C.

West Des Moines, IA United States
  Connect »

NECCR PrimaCare Research, LLC

Fall River, MA United States
  Connect »

Palm Research Center

Las Vegas, NV United States
  Connect »

Intend Research

Norman, OK United States
  Connect »

The Corvallis Clinic P.C.

Corvallis, OR United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Clinical Trials of Texas, Inc.

San Antonio, TX United States
  Connect »

GCM Medical Group PSC

San Juan, Puerto Rico
  Connect »